Exponent (EXPO) PT Raised to $75 at Cantor Fitzgerald Following 2Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Pre-Open Stock Movers 07/19: (AEZS) (VRTX) (SNI) Higher; (DRYS) (NTRS) (HDP) Lower (more...)
July 19, 2017 9:26 AM EDTToday's Pre-Open Stock Movers
Aeterna Zentaris Inc. (NASDAQ: AEZS) 48% HIGHER; announced that it has been notified by the U.S. Food and Drug Administration (FDA), that the Companys New Drug Application (NDA) seeking approval of Macrilen (macimorelin) for the evaluation of growth hormone deficiency in adults (AGHD) has been accepted as a complete response to the FDAs November 5, 2014 Complete Response Letter and granted a PDUFA date of December 30, 2017.
DryShips Inc. (NASDAQ: DRYS) 30.8% LOWER; announced today... More
After-Hours Stock Movers 07/18: (AEZS) (VRTX) (EXPO) Higher; (DRYS) (HDP) (IBM) (CSX) (UAL) Lower (more...)
July 18, 2017 6:06 PM EDTToday's After-Hours Movers
Aeterna Zentaris Inc. (NASDAQ: AEZS) 31.4% HIGHER; announced that it has been notified by the U.S. Food and Drug Administration (FDA), that the Companys New Drug Application (NDA) seeking approval of Macrilen (macimorelin) for the evaluation of growth hormone deficiency in adults (AGHD) has been accepted as a complete response to the FDAs November 5, 2014 Complete Response Letter and granted a PDUFA date of December 30, 2017.
DryShips Inc. (NASDAQ: DRYS) 26.9% LOWER; announced today that its Board... More
UPDATE: Exponent, Inc. (EXPO) Tops Q2 EPS by 10c
July 18, 2017 4:06 PM EDT(Updated - July 18, 2017 4:09 PM EDT)
(updated to add guidance outlook)
Exponent, Inc. (NASDAQ: EXPO) reported Q2 EPS of $0.51, $0.10 better than the analyst estimate of $0.41. Revenue for the quarter came in at $87.84 million versus the consensus estimate of $81.21... More
Exponent, Inc. (EXPO) Declares $0.21 Quarterly Dividend; 1.4% Yield
July 18, 2017 4:05 PM EDTExponent, Inc. (NASDAQ: EXPO) declared a quarterly dividend of $0.21 per share, or $0.84 annualized.
The dividend will be payable on September 22, 2017, to stockholders of record on September 1, 2017, with an ex-dividend date of August 30, 2017.
The annual yield on the dividend is 1.4 percent.
For a... More



